Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
The Pharmaceutical Market: Uganda

Uganda pharmaceutical market: Latest market research analysed


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-03-13 15:23:01 - The Pharmaceutical Market: Uganda - a new market research report on companiesandmarkets.com

While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Uganda may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks present in a market. With regards to assessing risks in the Ugandan healthcare sector, we have identified industry specific dangers (such as low per-capita spending and poor access to healthcare facilities) and those emanating from the state´s political/economic profile (such as high inflation) that call into question the likelihood of anticipated returns being realised over the assessed time period.

Headline Expenditure Projections

Pharmaceuticals: UGX676bn (US$268mn) in 2011 to UGX794bn (US$322mn) in 2012; +14.8% growth in local currency terms and +17.3% in

 

 

US dollar terms.

Healthcare: UGX3,942bn (US$1.56bn) in 2011 to UGX4,519bn (US$1.83bn) in 2012; 14.6% growth in local currency terms and 17.1% in US dollar terms.

Risk/Reward Ratings

In BMI´s Q1 13 BERs, Uganda is ranked 24th in the Middle East and Africa (MEA) region. While factors such as population growth and increasing healthcare needs will create a growing demand for pharmaceuticals, we note that a sizeable counterfeiting industry, poor healthcare funding, corruption, regulatory environment deficiencies and a number of other issues will conspire to keep Uganda in a similarly low position in the MEA matrix over the coming months.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com